Timely topic: Premalignant lesions associated with adenocarcinoma of the upper gastrointestinal tract

Pathology

Volumn 33, Issue 3, 2001, Pages 271-277

  Clouston, A D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adenocarcinoma; Barrett's esophagus; Barrett's oesophagus; Dysplasia; Intestinal metaplasia

Indexed keywords

ADENOCARCINOMA; ATROPHIC GASTRITIS; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER RISK; CARDITIS; DIGESTIVE SYSTEM INJURY; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; PRECANCER; REVIEW;

EID: 0034903750     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020120070830     Document Type: Article

References (48)

1. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett
2. The diagnosis of Barrett's esophagus: Goblets, goblets, goblets
3. The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus, and sequelae of therapy
4. Short segment Barrett's oesophagus: Prevalence, diagnosis and associations
5. Metaplastic columnar cells in Barrett's esophagus: A common and neglected cell type
6. Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction
7. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: Comparison with traditional long segment Barrett's esophagus
8. Pancreatic metaplasia in Barrett's esophagus. An immuno-histochemical study
9. Prevalence and significance of pancreatic acinar metaplasia at the gastroesophageal junction
10. Distribution of cytokeratin markers in Barrett's specialized columnar epithelium
11. Double muscularis mucosae in Barrett's esophagus
12. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach
13. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: An immunopathological study with clinical correlation
14. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus
15. Barrett's esophagus, dysplasia and adenocarcinoma
16. The economic impact of the diagnosis of dysplasia in Barrett's esophagus
17. Endoscopic surveillance of Barrett's esophagus: Risk stratification and cancer risk
18. Polypoid dysplasia in Barrett's esophagus: A clinicopathologic, immunohistochemical, and molecular study of five cases
19. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets
20. p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia
21. Barrett's esophagus. The significance of p53 in clinical practice
22. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases
23. Adenocarcinoma of the oesophago-gastric junction
24. Histology of the gastroesophageal junction: An autopsy study
25. The gastric cardia: Fact or fiction?
26. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction
27. Prevalence of metaplasia at the gastro-oesophageal junction
28. Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction
29. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?
30. Is typing of metaplasia at the squamocolumnar junction revealing its aetiology?
31. Inflammation and intestinal metaplasia of the gastric cardia: Helicobacter pylori, gastroesophageal reflux disease, or both
32. Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease
33. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: Implications for patient treatment and preventive strategies in Barrett's esophagus
34. Precursor lesions for cancer of the cardia
35. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia
36. Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia
37. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data
38. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus
39. Atrophy and atrophic gastritis: One step beyond the Sydney system
40. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors
41. The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma
42. Gastric cancer and intestinal metaplasia
43. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists
44. The Vienna classification of gastrointestinal epithelial neoplasia
45. Gastric dysplasia: The Padova international classification
46. Gastric epithelial dysplasia in the natural history of gastric cancer: A multicenter prospective follow-up study
47. Precursors of gastric carcinoma: A critical review with a brief description of early (curable) gastric cancer
48. Gastric carcinoma